Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

November 2007

Scored Tablets Make Pill Splitting Easier

ByLawrence Solomon, MD

November 1st 2007

Patient Preference for Colorectal Cancer Screening

ByRonald E. Myers. Author reply by Paul C. Schroy III, MD, MPH

November 1st 2007

Young Adult Smokers: Are They Different?

ByLeif I. Solberg, MD,Raymond G. Boyle, PhD, MPH,Maribet McCarty, PhD,Stephen E. Asche, MA,Merry Jo Thoele, MPH

November 1st 2007

Misperceptions of Patients vs Providers Regarding Medication-related Communication Issues

ByKate L. Lapane, PhD,Catherine E. Dub&eacute,Karen L. Schneider, PhD,Brian J. Quilliam, PhD

November 1st 2007

Adherence to K/DOQI Practice Guidelines for Bone Metabolism and Disease

ByTracey Hoy, BS,Maxine Fisher, PhD,Beth Barber, PhD,Rohit Borker, PhD,Brad Stolshek, PharmD,William Goodman, MD

November 1st 2007

The Past as Prologue: Future Directions in Clinical Performance Measurement in Ambulatory Care

ByL. Gregory Pawlson, MD, MPH

November 1st 2007

Glycemic Response to Newly Initiated Diabetes Therapies

ByAndrew J. Karter, PhD,Howard H. Moffet, MPH,Jennifer Liu, MPH,Melissa M. Parker, MS,Ameena T. Ahmed, MD,Alan S. Go, MD,Joe V. Selby, MD

November 1st 2007

Trending on AJMC

Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD

MRD-Guided CLL Treatment Duration: Personalization or Malpractice?

Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered

Blinatumomab Improves Outcomes, Toxicity in High-Risk Pediatric ALL: Martin Schrappe, MD, PhD

frontMIND Trial Shows PFS Benefit With Tafasitamab, Lenalidomide Combo in High-Risk DLBCL: Umberto Vitolo, MD